Jeffrey DeSano

1.6k citations
8 papers · 1.3k indexed · 1 hit paper · h-index 7
Topics
Cell death mechanisms and regulation (4 papers)MicroRNA in disease regulation (3 papers)RNA modifications and cancer (2 papers)
Partner nations
United StatesChina

In The Last Decade

Jeffrey DeSano

7 papers receiving 1.3k citations

Hit Papers

MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-In...20092026201420202009100200300400500

Peers

Jeffrey DeSano
Comparison fields: 5 of 93
  • Molecular Biology 1.0k
  • Cancer Research 826
  • Oncology 363
  • Complementary and alternative medicine 102
  • Immunology 65
Replace Jingnan Shen with:
Jingnan Shen China
Nermin Kahraman United States
Meng-Ning Wei China
Hongyan Jin China
Shangke Huang China
Fang Lou China
Xianping Shi China
Chengjian Shi China
Sima Orouei Iran
Xiaojun Yang China
Jeffrey DeSano relative to Jingnan Shen China Jingnan Shen's profile →
Citations per field
00.5×2.5×
Jingnan Shen · 1×
Citations per year

Countries citing papers authored by Jeffrey DeSano

Since Specialization
Citations

This map shows the geographic impact of Jeffrey DeSano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey DeSano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey DeSano more than expected).

Fields of papers citing papers by Jeffrey DeSano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey DeSano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey DeSano. The network helps show where Jeffrey DeSano may publish in the future.

Co-authorship network of co-authors of Jeffrey DeSano

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey DeSano. A scholar is included among the top collaborators of Jeffrey DeSano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey DeSano. Jeffrey DeSano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 0
2
Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer.
49
3 130
4 66
5 128
6
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cellsbreakdown →
558
7 50
8 338

About Jeffrey DeSano

Jeffrey DeSano is a scholar working on Toxicology, Complementary and alternative medicine and Cancer Research, having authored 8 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (826 citations), Molecular Biology (1.0k citations) and Oncology (363 citations). Jeffrey DeSano has collaborated with scholars based in United States and China. Frequent co-authors include Liang Xu, Yang Meng, Daiming Fan, Min Zhang, Qing Ji, Xinbao Hao, Theodore S. Lawrence, Wenhua Tang, Ling Li and Debing Xiang. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026